title: Radiesse nodule of the lips from a distant injection site: report of a case and consideration of etiology and management.
abstract: Radiesse was approved for cosmetic use by the US FDA in December of 2006. Prior to this approval it had been widely used off-label for a variety of areas including lip augmentation. With increased use, complications including nodule formation were reported. The formation of nodules at a site distant from the area of injection has not been reported to date. This report documents such a case and discusses possible etiologies and treatments for these distant nodules.
authors.forename: Kenneth Robert
authors.initials: KR
authors.lastname: Beer
mesh_terms: D001672:Biocompatible Materials / Q000008:administration & dosage / Q000009:adverse effects; D003357:Cosmetic Techniques / Q000009:adverse effects*; D017886:Durapatite / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage; D007267:Injections; D008047:Lip Diseases / Q000209:etiology*; D008875:Middle Aged; D015595:Skin Aging / Q000187:drug effects
chemical_list: D001672:Biocompatible Materials; D006820:Hyaluronic Acid; D017886:Durapatite